Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: Relationship with angiogenic factors in the cartilage

Acta Histochemica

Volumn 104, Issue 2, 2002, Pages 167-175

  Kusafuka, Kimihide ^a   Hiraki, Yuji ^b   Shukunami, Chisa ^b   Kayano, Teruo ^c   Takemura, Tamiko ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Angio inhibition; Angiogenic factor; Chondromodulin I; Fiblroblast growth factor 2; Immunohistochemistry; Transforming growth factor 1; Vascular endothelial growth factor

Indexed keywords

CELLS; ENDOCRINOLOGY; PROTEINS; TISSUE;

TRANSFORMING GROWTH FACTOR (TGF);

CARTILAGE;

AGGRECAN; ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; CHONDROMODULIN 1; COLLAGEN TYPE 2; FIBROBLAST GROWTH FACTOR 2; MATRIX PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGIOGENIC FACTOR; BIOLOGICAL MARKER; LECT1 PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ANGIOGENESIS; ARTICLE; BONE MARROW; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CLINICAL ARTICLE; ENCHONDRAL OSSIFICATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEWBORN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VERTEBRA; BIOSYNTHESIS; BONE DEVELOPMENT; DRUG EFFECT; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFANT; METABOLISM; NEURAL TUBE DEFECT; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; PRESCHOOL CHILD; SPINE;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANTIGENS, CD34; BIOLOGICAL MARKERS; CARTILAGE; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; OSTEOGENESIS; SPINAL DYSRAPHISM; SPINE; TISSUE EMBEDDING;

EID: 0035987930     PISSN: 00651281     EISSN: None     Source Type: Journal    
DOI: 10.1078/0065-1281-00642     Document Type: Article

References (37)

1. Post-translational processing of bovine chondromodulin-I
2. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
3. Expression of basic fibroblast growth factor in normal human tissues
4. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
5. The biology of vascular endothelial growth factor
6. Angiogenic factors
7. Prognostic significance of vascular endothelial growth factor in node-negative breast carcinoma
8. Inhibition of endothelial regeneration by type-beta transforming growth factor from platlets
9. Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I which stimulates growth of cultured chondrocytes
10. Identification of chondromodulin-I as a novel endothelial cell growth inhibitor; purification and its localization in the avascular zone of epiphyseal cartilage
11. Inhibition of DNA synthesis and tube morphogensis of cultured vascular endothelail cells by chondromodulin-I
12. Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells
13. Immunolocalization of vascular endothelial growth factor (VEGF) in human normal growth plate cartilages
14. Arg-XLys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway
15. Indentification of an autocrine chondrocyte colony-stimulating factor: Chondromodulin-I stimulates the colony formation of growth plate chondrocytes in agarose culture
16. Reduction in basic fibroblast growth factor receptor in coupled with terminal differentiation of chondrocytes
17. Transforming growth factor β1 stimulates type II collagen expression in cultured periosteum-derived cells
18. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation
19. A dual receptor system regulates for basic fibroblast growth factor activity: Minireview
20. Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: Immunohistochemical analysis
21. Immunohistochemical localization of member of the transforming growth factors (TGF)-β superfamily in normal human salivary glands and pleomorphic adenomas
22. Growth factors in wound healing: Single and synergistic effects on partial thickness porcine skin wounds
23. The transforming growth factor-β family
24. Transforming growth factor β1 and β2 are diffemtially ex-pressed in fibrotic liver disease
25. Enhancement of peritoneal chondrogenesis in vitro: High-response for transforming growth factor-β (TGF-β1)
26. Expression of vascular permeability factor / vascular endothelial growth factor in normal rat tissue
27. Transforming growth factor-β stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. excisional wound model
28. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
29. Gene expression during bone repair
30. In situ detection of basic fibroblast growth factor by highly specific antibody
31. Role of VEGF-Flt receptor system in normal and tumor angiogenesis
32. Spatiotem-poral pattern of the mouse chondromodulin-I gene expression and its reguratory role in vascular invasion into cartilage during endochondral bone formation
33. Cartilage-derived growth factor and antitumor factor: Past, present, future studies: Breakthrough and views
34. Correction of abnormal matrix formed by cmd/cmd chondrocytes in culture by exogenous added cartilage proteoglycan
35. Identification of a new member of the transforming growth factor β gene family
36. Recombinant expression and purification of transforming growth factor-β3, a potent growth regulator
37. Association of transforming growth factor β with prostatic cancer: Immunohistochemical study